VAPA-Oulu: Home-based Exercise Training in Cardiac Patients
Study Details
Study Description
Brief Summary
The investigators hypothesize that exercise training program guided by virtual augmented reality glasses or by video from computer screen used at home will improve motivation into exercise training and results in superior adherence to exercise training compared to current practice. The primary objectives of this research project are to study the effects of exercise training guidance by novel technology on 1) exercise capacity, 2) adherence to exercise training, 3) changes in cardiac autonomic function and 4) quality of life in acute coronary syndrome (ACS) patients.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
N/A |
Detailed Description
The subjects of the study will be recruited from the consecutive series of patients of men and women admitted to Oulu University Hospital due to an acute coronary syndrome (ACS). The study population will be randomized into control group (n=25) and study group (n=25) matched with age and gender. For all subjects, clinical status including quality of life questionnaire, exercise capacity and autonomic function measurements will be performed at baseline and after exercise training. Exercise training program is six months for both groups according to current guidelines. All the patients will have a detailed and personalized training prescription. Study group will have virtual augmented reality glasses or computer with training video to motivate and control exercise training prescription at home.
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Active Comparator: Current guidelines rehabilitation Exercise rehabilitation at home according to current guidelines. Training is guided and controlled by diary. |
Behavioral: Current guidelines rehabilitation
Exercise training intervention is six months and includes four to five aerobic and two strength training session a week according to American Heart Association guidelines for coronary artery disease patients. All the patients will have a detailed and personalized training diary.
|
| Experimental: Mobile device guided rehabilitation Exercise rehabilitation at home according to current guidelines. Training is guided and controlled by virtual augmented reality glasses or by mobile device. |
Behavioral: Mobile device guided rehabilitation
Exercise training intervention is six months and includes four to five aerobic and two strength training session a week according to American Heart Association guidelines for coronary artery disease patients. Study group will have virtual glasses or mobile device to motivate and control exercise training program.
|
Outcome Measures
Primary Outcome Measures
- Change in exercise capacity [Six months (baseline and 6 months)]
Change in maximal load during exercise stress test (metabolic equivalents)
Secondary Outcome Measures
- Adherence to exercise rehabilitation [Weekly from baseline to six months]
Realized training in relation to prescribed training over six months
- Change in the standard deviation of normal to normal intervals (SDNN) of heart rate variability [Six months (baseline and 6 months)]
Change in 24 h SDNN (ms)
- Change in very low frequency (VLF) of heart rate variability [Six months (baseline and 6 months)]
Change in 24 h VLF (ms^2)
- Change in low frequency (LF) of heart rate variability [Six months (baseline and 6 months)]
Change in 24 h LF (ms^2)
- Change in high frequency (HF) of heart rate variability [Six months (baseline and 6 months)]
Change in 24 h HF (ms^2)
- Change in fractal scaling exponent of heart rate variability [Six months (baseline and 6 months)]
Change in 24 h Fractal scaling exponent (a.u.)
- Change in baroreflex sensitivity [Six months (baseline and 6 months)]
Change in spontaneous baroreflex sensitivity by cross-spectral method (ms/mmHg)
- Change in quality of life [Six months (baseline and 6 months)]
Change in quality of life measured by 15-D questionaire
Eligibility Criteria
Criteria
Inclusion Criteria:
- Recent (< 1 month) acute coronary syndrome
Exclusion Criteria:
-
New York Heart Association (NYHA) functional classification class IV (heart failure)
-
unstable chest pain (angina pectoris, Canadian Cardiovascular Society grading of angina pectoris class 4)
-
ST-segment elevation myocardial infarction (STEMI)
-
implanted cardioverter defibrillation or pacemaker (or planned)
-
chronic atrial fibrillation
-
musculoskeletal disorder (unable to participate exercise training)
-
participation in competing clinical trial
-
severe peripheral atherosclerosis
-
retinopathy or neuropathy
-
dementia
-
life-expectancy due to other serious disease < 2 years or any other reason why patient is unable or unwilling to provide written informed consent.
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | University of Oulu | Oulu | Finland | 90014 |
Sponsors and Collaborators
- University of Oulu
- Business Finland
Investigators
- Principal Investigator: Mikko P Tulppo, PhD, University of Oulu
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 281/2016